Iron Dysregulation in Cardiovascular Diseases

被引:1
作者
Wang, Hui [1 ]
Huang, Zhongmin [1 ]
Du, Chenyan [1 ]
Dong, Mingqing [1 ]
Fragasso, Gabriele [1 ]
机构
[1] Chengdu Fifth Peoples Hosp, Geriatr Dis Inst Chengdu, Ctr Med Res & Translat, Chengdu 611137, Sichuan, Peoples R China
关键词
iron metabolism; homeostasis; cardiovascular disease; dysregulation; CHRONIC HEART-FAILURE; FERRIC CARBOXYMALTOSE; DEFICIENCY ANEMIA; HEREDITARY HEMOCHROMATOSIS; ENDOTHELIAL DYSFUNCTION; TRANSFERRIN RECEPTOR; EXERCISE CAPACITY; OXIDATIVE STRESS; OVERLOAD; HEPCIDIN;
D O I
10.31083/j.rcm2501016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Iron metabolism plays a crucial role in various physiological functions of the human body, as it is essential for the growth and development of almost all organisms. Dysregulated iron metabolism-manifested either as iron deficiency or overload-is a significant risk factor for the development of cardiovascular disease (CVD). Moreover, emerging evidence suggests that ferroptosis, a form of iron-dependent programed cell death, may also contribute to CVD development. Understanding the regulatory mechanisms of iron metabolism and ferroptosis in CVD is important for improving disease management. By integrating different perspectives and expertise in the field of CVD-related iron metabolism, this overview provides insights into iron metabolism and CVD, along with approaches for diagnosing, treating, and preventing CVD associated with iron dysregulation.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Hepcidin: Homeostasis and Diseases Related to Iron Metabolism
    Reichert, Cadiele Oliana
    da Cunha, Joel
    Levy, Debora
    Ferreira Maselli, Luciana Morganti
    Bydlowski, Sergio Paulo
    Spada, Celso
    ACTA HAEMATOLOGICA, 2017, 137 (04) : 220 - 236
  • [32] Impact of Sorbs2 dysfunction on cardiovascular diseases
    Xiong, Xiaowei
    Lee, Hon-Chi
    Lu, Tong
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (05):
  • [33] Noncoding RNA in age-related cardiovascular diseases
    Greco, Simona
    Gorospe, Myriam
    Martelli, Fabio
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2015, 83 : 142 - 155
  • [34] Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing
    Daba, Alina
    Gkouvatsos, Konstantinos
    Sebastiani, Giada
    Pantopoulos, Kostas
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (01): : 95 - 102
  • [35] Dysregulation of the sensory and regulatory pathways controlling cellular iron metabolism in unilateral obstructive nephropathy
    Votava, James A.
    Reese, Shannon R.
    Deck, Kathryn M.
    Nizzi, Christopher P.
    Anderson, Sheila A.
    Djamali, Arjang
    Eisenstein, Richard S.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2022, 322 (01) : F89 - F103
  • [36] Endothelial Dysfunction and Lung Capillary Injury in Cardiovascular Diseases
    Guazzi, Marco
    Phillips, Shane A.
    Arena, Ross
    Lavie, Carl J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2015, 57 (05) : 454 - 462
  • [37] Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations
    Toblli, Jorge E.
    Cao, Gabriel
    Angerosa, Margarita
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 187 : 196 - 197
  • [38] Impacts of Iron Metabolism Dysregulation on Alzheimer's Disease
    Jouini, Najla
    Saied, Zakaria
    Ben Sassi, Samia
    Nebli, Fatma
    Messaoud, Taieb
    Hentati, Faycel
    Belal, Samir
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 80 (04) : 1439 - 1450
  • [39] Intravenous iron therapy and the cardiovascular system: risks and benefits
    Del Vecchio, Lucia
    Ekart, Robert
    Ferro, Charles J.
    Malyszko, Jolanta
    Mark, Patrick B.
    Ortiz, Alberto
    Sarafidis, Pantelis
    Valdivielso, Jose M.
    Mallamaci, Francesca
    CLINICAL KIDNEY JOURNAL, 2021, 14 (04) : 1067 - 1076
  • [40] Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safety
    Blumenstein, Irina
    Shanbhag, Satish
    Langguth, Peter
    Kalra, Philip A.
    Zoller, Heinz
    Lim, Wendy
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (07) : 757 - 769